Streetbeat News

Products Services

CURLF

GTBIF

The Missouri Division of Cannabis Regulation has removed a recall on 15,000 products and transferred $13 million from the medical marijuana program to the Missouri Veterans Commission. Connecticut has increased transaction limits for adult-use cannabis customers. Indiana is considering the legalization of adult-use cannabis. Maryland is being urged to adopt reasonable zoning restrictions for cannabis businesses. Nevada regulators have granted conditional licenses for six more cannabis consumption lounges, including plans by Curaleaf Holdings (OTC:CURLF) and Green Thumb Industries (OTC:GTBIF).

Portfolio Pulse from Nicolás Jose Rodriguez

November 03, 2023 | 2:17 pm

NFLX

Netflix is considering streaming live boxing matches, according to the Wall Street Journal. This move could potentially diversify the company's content offerings and attract a new audience segment.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:04 pm

PODD

Insulet Corporation (NASDAQ:PODD) reported Q3 sales of $432.7 million, up 27.0%, beating the consensus of $414.383 million. The company also reported an adjusted EPS of $0.71, beating the consensus of $0.40. Insulet raised its FY23 revenue growth forecast to 26%-27% and expects total Omnipod growth between 29% and 30%. The company also received FDA clearance for the Omnipod 5 app on Apple iOS and plans to integrate Omnipod 5 with the Dexcom G7 by early 2024.

Portfolio Pulse from Vandana Singh

November 03, 2023 | 1:57 pm

MSFT

A developer has created a clone of the popular mobile game Angry Birds using GPT-4, Dall-E 3, and Midjourney. The game, called Angry Pumpkins, was completed in just 12 hours. The developer used Dall-E 3 and Midjourney for the visuals and backgrounds, while GPT-4 was used for programming and writing the code. This highlights the advancements in AI and its potential in game development.

Portfolio Pulse from Rounak Jain

November 03, 2023 | 1:41 pm

HOWL

Werewolf Therapeutics Inc (NASDAQ:HOWL) released preliminary results from an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or metastatic solid tumors. The data showed promising results with evidence of antitumor activity and no serious adverse events. The company's stock soared by 18.60% in the premarket session.

Portfolio Pulse from Vandana Singh

November 03, 2023 | 1:26 pm

JAZZ

The FDA has released a report detailing its 50 years of experience with cannabis research, highlighting an increased interest in studying cannabis and cannabis-derived products (CCDPs) as medical treatment options. The FDA is currently reviewing over 150 active investigational new drug applications (INDs) that evaluate CCDPs. The agency has not approved a marketing drug application for cannabis to treat a disease or condition, but it has approved one medicine, Epidiolex, a CBD-based drug for treating severe forms of epilepsy, produced by Jazz Pharmaceuticals. The FDA predicts an increase in INDs evaluating CCDPs.

Portfolio Pulse from Nina Zdinjak

November 03, 2023 | 1:24 pm

CZR

Caesars Entertainment, Inc. (NASDAQ:CZR) has launched its flagship sports wagering platform, Caesars Sportsbook, in Maine. The platform is now accepting sports wagers on mobile and desktop. The launch was made possible through a partnership with three of the Wabanaki Nations: the Houlton Band of Maliseet Indians, the Mi'kmaq Nation, and the Penobscot Nation. The revenues from sports wagering will be used by tribal governments and the State to support various sectors including law enforcement, health care, housing, and education throughout Maine.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:21 pm

CRON

Cronos Group Inc. (NASDAQ:CRON) has launched its award-winning cannabis brand Lord Jones in the Canadian adult-use cannabis market. The first product to launch are Lord Jones Hash Fusions pre-rolls, which are increasing in popularity among adult consumers. The product will be available in Alberta, British Columbia, Manitoba, PEI, Saskatchewan this month and in Ontario, Newfoundland, and New Brunswick by early 2024.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:18 pm

OMER

Omeros Corporation has announced the online publication of narsoplimab treatment results for 15 patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy. The results will be presented at the upcoming Annual Meeting of the American Society of Hematology.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:06 pm

PL

Planet Labs PBC has released the first ground testing results for NASA's CSP Program, validating the radio and antenna design, link margin, data rates, and latency. This is a step towards offering a real-time connectivity solution with Planet's LEO satellites. The RTcomms technology is persistent, ubiquitous, near-real, low data rate intersatellite link using global GEO C-band beams.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:05 pm